Gene therapy for islet transplantation. Improved understanding of aetiology of type I diabetes. Development of islet transplantation as a clinical therapeutic for type I diabetes. Improved efficacy of islet transplantation. Improved health for subjects with type I diabetes. Decreased diabetic complications. Improved quality of life for subjects with type I diabetes. Reduced burden on health system for management of diabetic complications for subjects with type I diabetes
Studies on the regulation of the pro-apoptotic protein Bim in mammalian development and cancer. This project is aimed at understanding the regulation of a gene, which is a tumour suppressor and is often mutated or down regulated in many different forms of cancers. A better understanding of how this gene works may eventually lead to better therapeutics to treat these cancers. This is relevant in the Australian context given that our aging population and obesity epidemics (the link between obesity ....Studies on the regulation of the pro-apoptotic protein Bim in mammalian development and cancer. This project is aimed at understanding the regulation of a gene, which is a tumour suppressor and is often mutated or down regulated in many different forms of cancers. A better understanding of how this gene works may eventually lead to better therapeutics to treat these cancers. This is relevant in the Australian context given that our aging population and obesity epidemics (the link between obesity, insulin resistance and various forms of cancers is well established) are leading to a rapid increase in new cancer cases, thus driving a rapid increase in demand for better treatments. This is particularly relevant in Indigenous health where obesity is on the rise following the transition from a traditional to an urban lifestyle.Read moreRead less
Development of an effective vaccine for chlamydial infection: optimisation of a non-toxic cholera toxin-based adjuvant to generate a protective mucosal response. Chlamydial genital infections are the most common sexually transmitted infection in Australia and the world and impose a major health burden on the community. Chlamydial infections are also associated with cardiovascular disease, Australia's biggest killer and asthma, another condition that has increased significantly in prevalence in t ....Development of an effective vaccine for chlamydial infection: optimisation of a non-toxic cholera toxin-based adjuvant to generate a protective mucosal response. Chlamydial genital infections are the most common sexually transmitted infection in Australia and the world and impose a major health burden on the community. Chlamydial infections are also associated with cardiovascular disease, Australia's biggest killer and asthma, another condition that has increased significantly in prevalence in the past 10 years. This project will evaluate the effectiveness of a new adjuvant as a first step towards the development of a vaccine to target these important infections.Read moreRead less
Development of a proto-type vaccine against gastrointestinal nematode larvae. Gastrointestinal parasites are the major cause of production losses in the Australian sheep and wool industries. Drug treatment is predominantly used to control infections but drug resistance has reached critical levels and is threatening the viability of sheep production in many rural areas. In collaboration with an international Animal Health company, we aim to develop vaccines against these parasites and provide a c ....Development of a proto-type vaccine against gastrointestinal nematode larvae. Gastrointestinal parasites are the major cause of production losses in the Australian sheep and wool industries. Drug treatment is predominantly used to control infections but drug resistance has reached critical levels and is threatening the viability of sheep production in many rural areas. In collaboration with an international Animal Health company, we aim to develop vaccines against these parasites and provide a clean, non-toxic alternative to drug treatment. The groundbreaking research involved in this project will also keep Australian animal scientists at the forefront of vaccine research and increase their capacity to attract further support from Industry.Read moreRead less
Identification of novel markers of inflammation. This project will benefit Australia as it will increase basic understanding of inflammatory processes, result in a new generation of diagnostics for inflammatory diseases that could lead to earlier diagnosis and to monitor treatment, resulting in large economic and health benefit. It may lead to development of novel new therapies using monoclonal antibodies to regulate processes in immune, cardiovascular and infectious diseases. The work will gene ....Identification of novel markers of inflammation. This project will benefit Australia as it will increase basic understanding of inflammatory processes, result in a new generation of diagnostics for inflammatory diseases that could lead to earlier diagnosis and to monitor treatment, resulting in large economic and health benefit. It may lead to development of novel new therapies using monoclonal antibodies to regulate processes in immune, cardiovascular and infectious diseases. The work will generate significant economic spin-offs to the Australian biotechnology industry and will further relationships and training between research and development.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE170100407
Funder
Australian Research Council
Funding Amount
$372,000.00
Summary
Biology of immune cells. This project aims to study immune cells that target harmful microbes by recognising by-products of their metabolism, and develop methods modulating their function. In particular, it aims to determine the immune recognition of the full range of microbial metabolites that activate these cells and unravel the mechanisms behind tolerance to nutrition-derived metabolites. This project is a potential opportunity for Australia to maximise its competitive edge in this field and ....Biology of immune cells. This project aims to study immune cells that target harmful microbes by recognising by-products of their metabolism, and develop methods modulating their function. In particular, it aims to determine the immune recognition of the full range of microbial metabolites that activate these cells and unravel the mechanisms behind tolerance to nutrition-derived metabolites. This project is a potential opportunity for Australia to maximise its competitive edge in this field and develop immune-modulatory agents ultimately leading to socioeconomic benefit.Read moreRead less
Molecular and immunological approaches to managing Australia's seafood allergy epidemic. Seafood is an increasingly important cause of food allergy. Novel insight into the functions of why and how proteins from seafood develop to potent allergens will lead to the development of better diagnostics and therapeutics. This will assist patients to better manage their serious food allergy.
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0883068
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
Dako ACIS III Cellular Image Acquisition and Analysis System. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. The ability to visualize and analyze cells and tissues from many different animal species, to elucidate both normal and abnormal functions, will be enhanced by the use of this technology. This will lead to production of quantitative statistical data that in turn will ....Dako ACIS III Cellular Image Acquisition and Analysis System. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. The ability to visualize and analyze cells and tissues from many different animal species, to elucidate both normal and abnormal functions, will be enhanced by the use of this technology. This will lead to production of quantitative statistical data that in turn will inform new approaches to improve and maintain the health of humans and other animals.Read moreRead less
Using transgenic plant-based production and delivery systems to develop an avian influenza vaccine. This project aims to provide proof-of-concept for the rapid production of plant-made vaccines of high strategic value to the poultry industry. Plant-made AI vaccines would help safeguard primary industries in Australia from exotic influenza strains and shield rural communities from the impact of stock losses. This collaboration will also contribute to the Molecular Farming industry by ensuring tha ....Using transgenic plant-based production and delivery systems to develop an avian influenza vaccine. This project aims to provide proof-of-concept for the rapid production of plant-made vaccines of high strategic value to the poultry industry. Plant-made AI vaccines would help safeguard primary industries in Australia from exotic influenza strains and shield rural communities from the impact of stock losses. This collaboration will also contribute to the Molecular Farming industry by ensuring that Australian interests are considered as this frontier technology tackles the challenges of turning academic research into marketable products. The key features of an oral plant-made AI vaccine, including rapid and non-egg based production, also make this an attractive technology for the future development of swine and human influenza vaccines.Read moreRead less